[Informe de investigación] Se espera que el mercado de sistemas de inyección sin aguja crezca de 131,64 millones de dólares en 2021 a 411,31 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 17,7 % entre 2022 y 2028.
Perspectivas del mercado y visión del analista:
Un sistema de inyección sin aguja es un dispositivo médico que administra medicamentos o vacunas en el cuerpo sin utilizar una aguja tradicional. En lugar de perforar la piel, el sistema utiliza tecnología de alta presión para forzar el medicamento a través de la piel y hacia el tejido subyacente. Este método suele ser el preferido por los pacientes que tienen miedo a las agujas y ansiedad asociada con las inyecciones. Los sistemas de inyección sin aguja también se utilizan en situaciones en las que las agujas tradicionales pueden suponer un riesgo de infección o lesión. Los dispositivos de inyección sin aguja utilizan presión para administrar el medicamento a través de la piel, eliminando la necesidad de una aguja tradicional. Esto puede ser más cómodo para los pacientes y reducir el riesgo de lesiones por pinchazos para los proveedores de atención médica.
Los factores que afectan positivamente el mercado de sistemas de inyección sin agujas son la creciente demanda de la prevalencia de pacientes y la promoción del tratamiento en todo el mundo, lo que aumenta la necesidad de sistemas de inyección sin agujas. Además, existen avances tecnológicos cada vez mayores y cada vez más iniciativas gubernamentales para mejorar la atención médica en el mercado de sistemas de inyección sin aguja. A pesar de los beneficios potenciales de los dispositivos de inyección sin aguja, algunas restricciones pueden afectar el mercado. Una limitación principal es el costo asociado con el desarrollo y la fabricación de estos dispositivos. La tecnología de inyección sin agujas puede ser más compleja y costosa de producir en comparación con los métodos tradicionales con agujas, lo que puede limitar su accesibilidad para algunos pacientes y proveedores de atención médica.
Impulsores de crecimiento:
Uno de los principales impulsores de los sistemas de inyección sin agujas es mejorar la comodidad y el cumplimiento del paciente. Muchos pacientes, especialmente los niños y aquellos con fobia a las agujas, experimentan ansiedad y miedo cuando se enfrentan a las inyecciones tradicionales con agujas. Al ofrecer una alternativa sin agujas, los proveedores de atención médica pueden mejorar la satisfacción de los usuarios/pacientes y el cumplimiento de los planes de tratamiento. Otro factor es la posibilidad de reducir el riesgo de lesiones por pinchazos con agujas y contaminaciones asociadas entre los trabajadores de la salud. Las lesiones por pinchazos pueden provocar graves riesgos para la salud, incluida la transmisión de patógenos transmitidos por la sangre, como el VIH y la hepatitis. Al eliminar la necesidad de agujas, los sistemas de inyección sin agujas pueden ayudar a proteger a los trabajadores de la salud de estos riesgos laborales.
Además, los sistemas de inyección sin agujas ofrecen la posibilidad de lograr aplicaciones más precisas y entrega constante de medicamentos. La tecnología de alta presión de estos sistemas puede garantizar que los medicamentos se administren a la profundidad correcta y con la fuerza adecuada, lo que conduce a mejores resultados del tratamiento. En general, el impulso hacia los sistemas de inyección sin agujas está impulsado por el deseo de mejorar la comodidad del paciente, mejorar la seguridad de los trabajadores de la salud y optimizar la administración de medicamentos y vacunas. A medida que avanza la tecnología, se espera que crezca el desarrollo y la adopción de sistemas de inyección sin agujas en la industria de la salud.
Oportunidades:< /u>
La creciente demanda de métodos de administración de medicamentos más convenientes y menos invasivos presenta una oportunidad importante para el mercado de las inyecciones sin agujas. Los dispositivos de inyección sin agujas ofrecen una alternativa conveniente e indolora a las inyecciones tradicionales, lo que facilita a los pacientes el cumplimiento de sus regímenes de medicación. Estos dispositivos utilizan tecnologías como inyectores a chorro o microagujas para administrar medicamentos sin aguja, brindando una experiencia más cómoda a los pacientes. Esto puede mejorar la adherencia a la medicación y los resultados de los pacientes, especialmente en el caso de enfermedades crónicas que requieren inyecciones frecuentes. Además, los dispositivos de inyección sin agujas pueden ayudar a reducir las posibilidades de sufrir pinchazos y la transmisión de infecciones transmitidas por la sangre, lo que los convierte en una opción más segura para los pacientes y los proveedores de atención médica. A medida que continúa creciendo la demanda de métodos de administración de medicamentos más convenientes y eficaces, el mercado de las inyecciones sin agujas tiene el potencial de expandirse y ofrece soluciones innovadoras para satisfacer las necesidades de los pacientes y los proveedores de atención médica. Esto presenta una importante oportunidad para que las empresas operativas del sector sanitario desarrollen y comercialicen dispositivos de inyección sin agujas que puedan tener un impacto positivo en la atención al paciente y en los resultados del tratamiento.
Perspectivas estratégicas
Segmentación y alcance del informe:
El “Mercado de sistemas de inyección sin aguja” está segmentado según tipo, producto, tecnología, usabilidad, sitio de entrega, aplicación, usuario final y geografía. Según el tipo, el mercado se segmenta en inyectores sin agujas a base de líquido, inyectores sin agujas a base de proyectiles/depósito e inyectores sin agujas a base de polvo. En términos de producto, el mercado de sistemas de inyección sin aguja se segmenta en inyectores rellenables sin aguja e inyectores precargados sin aguja. Según la tecnología, el mercado se clasifica en inyectores sin aguja basados en chorro, inyectores sin aguja globales de resorte, inyectores sin aguja accionados por láser e inyectores sin aguja basados en vibración. Según la usabilidad, el mercado se segmenta en inyectores desechables sin agujas e inyectores reutilizables sin agujas. Según el lugar de entrega, el mercado se segmenta en inyectores subcutáneos, inyectores intramusculares e inyectores intradérmicos. En términos de aplicación, el mercado de sistemas de inyección sin aguja se segmenta en administración de vacunas, administración de insulina, oncología, manejo del dolor y otros. Según el usuario final, el mercado se segmenta en hospitales y clínicas, entornos de atención domiciliaria, laboratorios de investigación, empresas farmacéuticas y biotecnológicas, entre otros. El mercado de Sistemas de inyección sin agujas, según la geografía, está segmentado en América del Norte (EE. UU., Canadá y México), Europa (Alemania, Francia, Italia, Reino Unido, España y resto de Europa), Asia Pacífico (Australia, China, Japón, India, Corea del Sur y resto de Asia Pacífico), Medio Oriente y Asia. África (Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos y resto de Medio Oriente y África) y Sur y África. Centroamérica (Brasil, Argentina y resto de Centro y Suramérica).
Análisis segmentario:En noviembre de 2020, PharmaJet, un fabricante líder de dispositivos de inyección sin aguja, anunció una asociación estratégica con Mundipharma, una empresa farmacéutica global. Esta asociación tenía como objetivo ampliar la disponibilidad de la tecnología de inyección sin aguja de PharmaJet para administrar vacunas y medicamentos.
Panorama competitivo y empresas clave:
PharmaJet, Portal Instruments, Medical International Technology, Inc., NuGen Medical Devices, Crossject SA, Antares Pharma, 3M, Injex Pharma AG, NovaXS Biotech, INVIO Pharmaceutical Inc. son las principales empresas de sistemas de inyección sin agujas. Estas empresas se centran en nuevas tecnologías, avances en productos existentes y expansiones geográficas para satisfacer la creciente demanda de los consumidores en todo el mundo.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Asia Pacific is expected to be the fastest-growing region in the needle free injection system market over the forecast period due to growing investments from international players in China and India, improving government support in countries, collaboration of research organizations, and advancing healthcare infrastructure.
The factors that are driving the growth of the needle free injection system market are increasing incidence of communicable diseases due to needlestick injuries and rising demand for self-injection devices are the major factors contributing to the growth of the Needle Free Injection System industry.
The needle free injection system market is expected to be valued at US$ 411,312.81 thousands in 2028.
The fillable needle-free injectors segment held the largest share of the market in the global needle free injection system market contributing a market share of 63.6% in 2021.
Needle-free injection system is a jet injector that delivers medicine to intramuscular and subcutaneous tissue depths without needles. Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, advantages of drug delivery technology, increasing demand for self-injection devices.
The Needle Free Injection System market is estimated to be valued at US$ 131,640.54 thousands in 2021.
The CAGR value of the needle free injection system market during the forecasted period of 2022-2028 is 17.7%
The Needle Free Injection System market majorly consists of the players, such as Crossject; INOVIO Pharmaceuticals; Zealand Pharma A/S; PharmaJet; Portal Instruments; Medical International Technologies (MIT Canada) Inc.; NuGen Medical Devices; Ferring B.V.; National Medical Products, Inc.; and Aijex Pharma International Inc. among others.
The List of Companies - Needle Free Injector System Market
- Crossject
- INOVIO Pharmaceuticals
- Zealand Pharma A/S
- PharmaJet
- Portal Instruments
- Medical International Technologies (MIT Canada) Inc.
- NuGen Medical Devices
- Ferring B.V.
- National Medical Products, Inc.
- Aijex Pharma International Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2022
Digital PCR (dPCR) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Aug 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography